As per date, around 20 million COVID-19 cases reported from across the globe due to a tiny
125 nm sized virus: SARS-CoV-2 which has created a pandemic and left an unforgettable …

The novel coronavirus disease, caused by severe acute respiratory coronavirus 2 (SARS-
CoV-2), rapidly spreading around the world, poses a major threat to the global public health …

The novel coronavirus, COVID-19, caused by SARS-CoV-2, is a global health pandemic that
started in December 2019. The effective drug target among coronaviruses is the main …

Drug repurposing requires a limited resource, cost-effective and faster method to combat
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Therefore, this in silico …

The SARS-CoV-2 was confirmed to cause the global pandemic of coronavirus disease 2019
(COVID-19). The 3-chymotrypsin-like protease (3CLpro), an essential enzyme for viral …

Abstract Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is the causative
agent of the pandemic COVID-19 disease that affects human respiratory function. Despite …

Atazanavir (ATZ) is an antiviral drug synthesized. ATZ is being investigated for potential
application against the Coronavirus 2019-nCoV. To find candidate drugs for 2019-nCoV, we …

The SARS-CoV-2 virus is a major problem in the world right now. Currently, all the attention
of research centers and governments globally are focused on the investigation of …

SARS-CoV-2 is a new generation of coronavirus, which was first determined in Wuhan,
China, in December 2019. So far, however, there no effective treatment has been found to …

The recent outbreak of COVID-19 caused by a new human coronavirus called SARS-CoV-2,
is continually causing worldwide human infections and deaths. The main protease (3CLpro) …